Novavax, Inc. NVAX

10.63 0.03 0.28% as of 25 Sep
Market cap
$1.8B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
265.79 185.54 102.98 81.77 804.93 1,526.61 1,347.19 578.93 933.74 745.96
Receivables
0.00 — — 7.50 262.01 454.99 82.38 297.24 108.29 106.45
Inventory
— — — — — 8.87 36.68 41.70 8.75 11.55
Other current assets
22.00 18.00 16.00 8.00 181.00 174.00 237.00 — — 87.51
Total current assets
287.83 203.31 119.28 97.25 1,248.20 2,155.12 1,703.39 1,143.89 1,128.94 978.28
Property, Plant, Equpment (Net)
40.18 35.99 28.43 11.45 179.95 225.74 294.25 305.77 138.41 44.80
Goodwill and Intangible Assets (Total)
60.90 61.44 58.51 56.74 141.10 131.48 126.33 127.45 107.48 113.46
Long-term assets (Other)
5.39 1.76 1.77 7.53 13.22 24.29 28.47 35.16 24.00 17.08
Total non-current assets
106.47 99.18 88.70 75.71 334.28 421.63 555.29 653.60 431.48 198.24
Total Assets
394.30 302.49 207.98 172.96 1,582.48 2,576.75 2,258.68 1,797.49 1,560.42 1,176.51
Notes Payable
— — — — — — 324.88 — — —
Accounts Payable
5.69 5.61 9.30 2.91 54.33 127.05 216.52 132.61 41.58 24.58
Accrued Expenses
29.59 34.69 24.63 19.95 137.39 673.73 591.16 394.67 211.17 107.17
Current Part of Capital Lease
— — — — 105.86 130.53 27.20 5.14 7.01 2.51
Current Revenue (Deferred)
30.08 25.63 10.01 1.68 273.23 1,422.94 370.14 241.31 675.07 140.05
Other current liabilities
1.06 7.75 1.60 1.26 8.86 36.06 930.06 861.41 219.60 185.65
Total current liabilities
66.41 73.68 45.54 25.80 579.67 2,390.32 2,459.94 1,635.14 1,154.42 459.95
Long Term Debt (Total)
316.34 317.76 319.19 320.61 362.12 323.46 197.70 223.94 223.41 246.30
Non-current Revenue (Deferred)
2.50 2.50 2.50 3.00 — 172.53 179.41 622.21 446.82 358.94
Non-current Liabilities (Other)
14.60 10.29 8.69 12.57 13.48 42.12 55.70 33.13 359.61 239.07
Total non-current liabilities
333.44 330.55 330.37 333.18 375.60 538.11 432.81 879.28 1,029.84 844.32
Total liabilities
399.85 404.23 375.91 358.97 955.27 2,928.43 2,892.76 2,514.42 2,184.26 1,304.27
Additional Paid In Capital
936.00 1,020.46 1,144.62 1,260.55 2,535.48 3,351.97 3,737.98 4,192.16 4,501.40 4,539.76
Common Stock (Net)
2.72 3.24 0.19 0.32 0.71 0.76 0.87 1.41 1.62 1.65
Retained Earnings
(930.00) (1,114.36) (1,299.11) (1,431.80) (1,874.20) (3,617.95) (4,275.89) (4,820.95) (5,008.45) (4,568.15)
Treasury Stock
2.45 2.45 2.45 2.58 41.81 85.10 90.66 92.27 95.85 103.02
Common Equity (Total)
(5.55) (101.73) (167.94) (186.02) 627.21 (351.67) (634.08) (716.93) (623.84) (127.75)
Shareholders Equity (Total)
(5.55) (101.73) (167.93) (186.02) 627.21 (351.67) (634.08) (716.93) (623.84) (127.75)
Shareholders Equity and Liabilities (Total)
394.30 302.49 207.98 172.96 1,582.48 2,576.75 2,258.68 1,797.49 1,560.42 1,176.51
Shares (Common)
13.56 16.16 19.22 32.35 70.95 75.84 86.04 139.51 160.42 162.58
Shareholders Equity (Tangible)
(66.44) (163.17) (226.44) (242.75) 486.11 (483.15) (760.41) (844.38) (731.32) (241.22)
Net Debt
50.55 132.23 216.21 238.84 (442.81) (1,203.15) (1,149.48) (354.99) (710.33) (499.66)
Total Debt
316.34 317.76 319.19 320.61 362.12 323.46 197.70 223.94 223.41 246.30

Fold the line items

In millions of $ except per-share values · columns are period end dates